Kristen A Phair, James W Carpenter, Nicole Smee, Carl B Myers, Lisa M Pohlman
Index: J. Zoo Wildl. Med. 43(1) , 162-7, (2012)
Full Text: HTML
An 8-yr-old, captive, spayed, female maned wolf (Chrysocyon brachyurus) developed progressive lethargy and weakness over a 24-hr period. Clinical signs included vomiting, recumbency, horizontal nystagmus, possible blindness, pale icteric mucus membranes, and port-wine colored urine. A complete blood cell count revealed severe anemia (packed cell volume [PCV], 6%) and intraerythrocytic piroplasms consistent with a Babesia species. Polymerase chain reaction testing later confirmed babesiosis. The wolf was treated with imidocarb dipropionate, antibiotics, and fluid therapy. A whole-blood transfusion from a sibling maned wolf also was performed. Despite aggressive treatment, the wolf failed to improve and was euthanized. To the authors' knowledge, this is the first documented case of babesiosis in a captive maned wolf in North America. Surveillance of infectious diseases in captive and wild maned wolf populations should be expanded to include screening for Babesia species. Tick control also should be implemented to prevent and decrease transmission of the disease to this endangered species.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Imidocarb dipropionate
CAS:55750-06-6 |
C25H32N6O5 |
Comparison of glycopyrrolate and atropine in ameliorating th...
2013-09-01 [Equine Vet. J. 45(5) , 625-9, (2013)] |
Failure of combination therapy with imidocarb dipropionate a...
2011-09-01 [Parasitol. Res. 109(3) , 919-26, (2011)] |
Alterations in some blood coagulation parameters in naturall...
2009-06-01 [Acta Vet. Hung. 57(2) , 295-304, (2009)] |
Alterations of blood parameters after intramuscular administ...
2012-04-01 [Drug Chem. Toxicol. 35(2) , 162-6, (2012)] |
Induced mitotic homologous recombination by the babesicide i...
2012-01-01 [Genet. Mol. Res. 11(3) , 1810-8, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved